Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and antiviral drugs. Its chiral cyclopropylamine structure enables selective binding in biological systems, making it valuable in creating enantiomerically pure active pharmaceutical ingredients. Commonly employed in the preparation of hepatitis C virus (HCV) NS3/4A protease inhibitors due to its ability to enhance metabolic stability and improve pharmacokinetic properties. Also utilized in medicinal chemistry research for optimizing drug candidates targeting central nervous system disorders, where the fluorinated aryl group contributes to blood-brain barrier penetration.